SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-050702
Filing Date
2017-08-09
Accepted
2017-08-09 16:12:15
Documents
70
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-13338_110q.htm 10-Q 1505061
2 EX-31.1 a17-13338_1ex31d1.htm EX-31.1 10192
3 EX-31.2 a17-13338_1ex31d2.htm EX-31.2 10030
4 EX-32.1 a17-13338_1ex32d1.htm EX-32.1 6049
5 EX-32.2 a17-13338_1ex32d2.htm EX-32.2 6152
  Complete submission text file 0001104659-17-050702.txt   8960974

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT jagx-20170630.xml EX-101.INS 1800710
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jagx-20170630.xsd EX-101.SCH 88613
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jagx-20170630_cal.xml EX-101.CAL 65812
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jagx-20170630_def.xml EX-101.DEF 356698
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT jagx-20170630_lab.xml EX-101.LAB 699719
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jagx-20170630_pre.xml EX-101.PRE 541593
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 171017997
SIC: 2834 Pharmaceutical Preparations